QAA — Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens Class II

FDA Device Classification

FDA product code QAA covers "Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens", a Class II medical device regulated under 21 CFR 866.3376. Submissions are reviewed by the Microbiology panel. At least 1 recent 510(k) clearance has been granted under this product code.

Classification Details

Product Code
QAA
Device Class
Class II
Regulation Number
866.3376
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
DEN170041dxnaGeneSTAT.MDx Coccidioides AssayNovember 29, 2017